NeuPath Health Inc Cash Flow Reinvestment Rate

Latest as of June 2026: 0.31x

NeuPath Health Inc cash flow reinvestment rate. NeuPath Health Inc (NPTH) has a Cash Flow Reinvestment Rate of 0.31x as of June 2026, reinvesting CA$281.00K (capex CA$281.00K ) from operating cash flow of CA$906.00K. Explore cash flow to debt ratio of NeuPath Health Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.31x
(Capex + Investments) / Operating CF

Total Reinvested

CA$281.00K
Capex + Investments

Operating Cash Flow

CA$906.00K
CAD

Capital Expenditures

CA$281.00K
CAD

Cash Flow Reinvestment Rate of NeuPath Health Inc (2021–2025)

Cash flow reinvestment rate of NeuPath Health Inc from 2021 to 2025. Historical reinvestment intensity for NeuPath Health Inc across 5 annual periods. Explore NeuPath Health Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

NeuPath Health Inc Cash Flow Reinvestment Rate by Year (2021–2025)

NeuPath Health Inc cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for NeuPath Health Inc. For the full cash flow conversion analysis, see NPTH cash generation efficiency.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2025 0.22x CA$863.00K CA$4.00 Million CA$863.00K ▼ -72.7%
2024 0.79x CA$2.06 Million CA$2.61 Million CA$948.00K ▲ +22.9%
2023 0.64x CA$1.94 Million CA$3.03 Million CA$353.00K ▼ -83.7%
2022 3.93x CA$2.90 Million CA$738.00K CA$1.23 Million ▲ +93.1%
2021 2.04x CA$3.91 Million CA$1.92 Million CA$411.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow